bioRxiv Science⌕ Search

Biology subjects

Parolini, L.

Publications and source records attributed to Parolini, L..

2 recordsLinked to original sources

A microfluidic device for controlled exposure of transgenic Ciona intestinalis larvae to chemical stimuli demonstrates they can respond to carbon dioxide.

The larva of the ascidian Ciona intestinalis controls a small repertoire of behaviours with a simple nervous system in which each cell is identifiable. As such it offers the prospect of building a cohesive cell-level picture of how a nervous system integrates sensory inputs to produce specific behavioural outcomes. Here, we report the development of a microfluidic chip in which larvae can be immobilised and exposed to chemical stimuli. We generate transgenic larvae in which the calcium ion reporter GCaMP6m is expressed in a defined population of cells, allowing us to record real-time neural activity following stimulation. We then use this to establish that some cell populations can sense dissolved carbon dioxide. We also leverage genome and transcriptome data coupled with molecular evolutionary analysis to identify putative chemoreceptors of the MS4A family in Ciona. Our study demonstrates that Ciona larvae can respond to dissolved carbon dioxide, identifies the cells that are likely responsible for chemosensation, and establishes a chip based imaging platform coupled with transgenic technology that could be adapted to establish where other stimuli are sensed and how such incoming signals are processed in the brain to yield behavioural output.

evolutionary biology↗

Expression of type I interferon-associated genes at antiretroviral therapy interruption predicts HIV virological rebound

Although certain individuals with HIV infection can stop antiretroviral therapy (ART) without evidence of viral load rebound, the mechanisms under-pinning post-treatment control remain unclear. Twelve individuals who had received 12 months of ART from primary HIV infection and then undertook a TI were sampled at the time of stopping therapy. Using RNA-Seq we explored gene expression in CD4 T cells to look for evidence of a mechanism that might underpin virological rebound and lead to discovery of an associated biomarker. Using independent analysis tools, genes associated with the type I interferon response were strongly associated with a delayed time to viral rebound following TI. These are the first data we are aware of that link transcriptomic signatures associated with innate immunity with control following TI. While these results need to be confirmed in larger trials, they could help define a strategy for new therapies and identify new biomarkers for remission.

microbiology↗